跳至主要内容
临床试验/NCT01986257
NCT01986257已完成不适用

Emotion Regulation Group Therapy (ERGT) for Women Engaging in Non-suicidal Self-Injury (NSSI) - an Effectiveness Study

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2013年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
97
试验地点
2
主要终点
Frequency of non-suicidal self-injury as measured by Deliberate Self-Harm Inventory (DSHI)

研究概览

简要总结

The primary aim is to investigate the effectiveness of Emotion Regulation Group Therapy (ERGT) for women who self-harm in ordinary psychiatric outpatient health care.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • NSSI a minimum of three times in the last six months
  • Meets at least three criteria for Borderline Personality Disorder according to DSM-IV-TR
  • Contact with an other individual therapist, psychiatrist, "case manager" or equal

排除标准

  • Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment
  • Other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand
  • Bipolar disorder I or primary psychosis
  • Current substance dependence (the last month)
  • Current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse)
  • Insufficient Swedish language skills
  • Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)

研究组 & 干预措施

Emotion Regulation Group Therapy (ERGT).

Experimental

干预措施: Emotion Regulation Group Therapy (ERGT). (Behavioral)

结局指标

主要结局

Frequency of non-suicidal self-injury as measured by Deliberate Self-Harm Inventory (DSHI)

时间窗: Baseline (from inclusion to treatment start), (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.

Change from Baseline in deliberate self-harm after 14 weeks and at 6- and 12 months after treatment has ended.

次要结局

  • Diary questionnaire (DQ)(Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.)
  • Borderline Symptom List Behavior supplement (BSL-supplement)(Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks), and six and twelve months follow-up.)
  • Difficulties in Emotion Regulation Scale (DERS)(Baseline (from inclusion to treatment start), pre-treatment (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (14 weeks) and six and twelve months follow-up.)
  • The Borderline Evaluation of Severity over Time (BEST).(Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.)
  • The Depression Anxiety Stress Scales (DASS)(Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.)
  • Inventory of Interpersonal Problems - Borderline Personality Disorder (IIP-BPD)(Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.)
  • Euroqol-5D (EQ-5D)(Baseline, post-treatment (14 weeks) and six and twelve months follow-up.)
  • Sheehan Disability Scale (SDS)(Pre-treatment (7 days prior to treatment start), post-treatment (14 weeks) and six and twelve months follow-up.)
  • Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P)(Baseline, post-treatment (14 weeks) and six and twelve months follow-up.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Clara Hellner Gumpert

Ph.D.

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验